3-Iodo-L-tyrosine | |
| Names | |
|---|---|
| IUPAC name (2S)-2-Amino-3-(4-hydroxy-3-iodophenyl)propanoic acid | |
| Other names Monoiodotyrosine; MIT [1] | |
| Identifiers | |
| |
3D model (JSmol) | |
| ChEMBL | |
| ChemSpider | |
| DrugBank | |
| ECHA InfoCard | 100.000.677 |
| MeSH | Monoiodotyrosine |
PubChem CID | |
| UNII | |
CompTox Dashboard (EPA) | |
| |
| |
| Properties | |
| C9H10INO3 | |
| Molar mass | 307.087 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
3-Iodotyrosine is an intermediate in the synthesis of thyroid hormones which is derived from iodination of tyrosine at the meta-position of the benzene ring. One unit can combine with diiodotyrosine to form triiodothyronine, as occurs in the colloid of the thyroid follicle. Two units can combine to form 3,3'-diiodothyronine.
3-Iodotyrosine is a reversible inhibitor of the enzyme tyrosine hydroxylase. [2]
3-Iodotyrosine, a pathway inhibitor in the synthesis of the neurotransmitter dopamine, was used to determine the effects of decreased dopamine levels in social spacing of Drosophila melanogaster . 3-4 day old flies that were fed 3-iodotyrosine for 24 hours were shown to have altered dopamine levels. [3]